WallStreetZenWallStreetZen

NASDAQ: DRTS
Alpha Tau Medical Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for DRTS

Based on 3 analysts offering 12 month price targets for Alpha Tau Medical Ltd.
Min Forecast
$7.00+181.12%
Avg Forecast
$8.00+221.29%
Max Forecast
$9.00+261.45%

Should I buy or sell DRTS stock?

Based on 3 analysts offering ratings for Alpha Tau Medical Ltd.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DRTS stock forecasts and price targets.

DRTS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-12
lockedlocked$00.00+00.00%2024-03-08
lockedlocked$00.00+00.00%2023-12-15

1 of 1

Forecast return on equity

Is DRTS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is DRTS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

DRTS revenue forecast

What is DRTS's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.9M
Avg 2 year Forecast
$4.1M
Avg 3 year Forecast
$27.9M

DRTS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DRTS$2.49$8.00+221.29%Strong Buy
GNFT$3.49$11.00+215.19%Buy
OMER$3.04N/AN/A
KOD$3.38$3.33-1.39%Strong Sell
CADL$6.05$11.00+81.82%Buy
View Top Biotech Stocks

Alpha Tau Medical Stock Forecast FAQ

Is Alpha Tau Medical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: DRTS) stock is to Strong Buy DRTS stock.

Out of 3 analysts, 2 (66.67%) are recommending DRTS as a Strong Buy, 1 (33.33%) are recommending DRTS as a Buy, 0 (0%) are recommending DRTS as a Hold, 0 (0%) are recommending DRTS as a Sell, and 0 (0%) are recommending DRTS as a Strong Sell.

If you're new to stock investing, here's how to buy Alpha Tau Medical stock.

What is DRTS's revenue growth forecast for 2025-2027?

(NASDAQ: DRTS) Alpha Tau Medical's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Alpha Tau Medical's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast DRTS's revenue for 2025 to be $133,070,869, with the lowest DRTS revenue forecast at $133,070,869, and the highest DRTS revenue forecast at $133,070,869. On average, 1 Wall Street analysts forecast DRTS's revenue for 2026 to be $283,559,391, with the lowest DRTS revenue forecast at $283,559,391, and the highest DRTS revenue forecast at $283,559,391.

In 2027, DRTS is forecast to generate $1,941,023,250 in revenue, with the lowest revenue forecast at $1,941,023,250 and the highest revenue forecast at $1,941,023,250.

What is DRTS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: DRTS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is DRTS's Price Target?

According to 3 Wall Street analysts that have issued a 1 year DRTS price target, the average DRTS price target is $8.00, with the highest DRTS stock price forecast at $9.00 and the lowest DRTS stock price forecast at $7.00.

On average, Wall Street analysts predict that Alpha Tau Medical's share price could reach $8.00 by Mar 12, 2025. The average Alpha Tau Medical stock price prediction forecasts a potential upside of 221.29% from the current DRTS share price of $2.49.

What is DRTS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: DRTS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.